Myocardial stress perfusion-fibrosis imaging pattern in sarcoidosis, assessed by cardiovascular magnetic resonance imaging

International Journal of Cardiology

Volumn 172, Issue 2, 2014, Pages 501-503

  Mavrogeni, Sophie ^a   Kouranos, Vasilios ^b   Sfikakis, Petros P ^c   Bratis, Konstantinos ^a   Kitas, George D ^d   Manali, Efrosini ^b   Perros, Elias ^e   Vlasis, Kostas ^b   Rapti, Aggeliki ^f   Koulouris, Nikolaos ^b   Van Wijk, Kees ^g   Hautemann, David ^g   Reiber, Johan H C ^g   Kolovou, Genovefa ^a   Tzelepis, George E ^b   Gialafos, Elias ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e IASO GENERAL HOSPITAL   (Greece)

^f SOTIRIA GENERAL HOSPITAL   (Greece)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular magnetic resonance (CMR); Late gadolinium enhancement; Myocarditis; Sarcoidosis; Stress perfusion fibrosis CMR

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

ADULT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; LETTER; MALE; MYOCARDIAL STRESS PERFUSION FIBROSIS IMAGING; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SARCOIDOSIS; CARDIOMYOPATHIES; CASE CONTROL STUDY; DIAGNOSTIC USE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CONTRAST MEDIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SARCOIDOSIS;

EID: 84900665617     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.01.006     Document Type: Article

References (19)

1. J. Barnard, and L.S. Newman Sarcoidosis: immunology, rheumatic involvement, and therapeutics Curr Opin Rheumatol 13 1 2001 84 91
2. O.P. Sharma, A. Maheshwari, and K. Thaker Myocardial sarcoidosis Chest 103 1993 253 258
3. J. Schulz-Menger, R. Wassmuth, and H. Abdel-Aty et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance Heart 92 2006 399 400
4. J.P. Smedema, G. Snoep, and M.P. van Kroonenburgh et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in The Netherlands Chest 128 2005 30 35
5. S. Greulich, C.C. Deluigi, and S. Gloekler et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis JACC Cardiovasc Imaging 6 4 2013 501 511
6. C.Z. Chiu, S. Nakatani, and G. Zhang et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis Am J Cardiol 95 2005 143 146
7. J. Vilaseca, J. Guardia, and A. Cuxart et al. Granulomatous hepatitis. Etiologic study of 107 cases Med Clin (Barc) 72 7 1979 272 275
8. P. Tellier, D. Valeyre, A. Nitenberg, J.M. Foult, G. Bedig, and J.P. Battesti Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole Eur J Nucl Med 11 6-7 1985 201 204
9. R. Blankstein, M. Osborne, and M. Naya et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis J Am Coll Cardiol Oct 1 2013 [doi:pii: S0735-1097(13)05455-7]
10. S. Mavrogeni, P.P. Sfikakis, and E. Gialafos et al. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases Arthritis Care Res (Hoboken) 66 2014 104 112
11. S. Mavrogeni, F. Cantini, and G.M. Pohost Systemic vasculitis: an underestimated cause of heart failure - assessment by cardiovascular magnetic resonance Rev Cardiovasc Med 14 1 2013 49 55
12. S. Mavrogeni, P.P. Sfikakis, and E. Gialafos et al. Diffuse, subendocardial vasculitis. A new entity identified by cardiovascular magnetic resonance and its clinical implications Int J Cardiol 168 2013 2971 2972 [pii: S01675273(13)00761]
13. S.A. Timmer, T. Germans, and M.J. Götte et al. Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury Am J Cardiol 107 10 2011 1522 1528
14. W.J. Paulus, and C. Tschöpe A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation J Am Coll Cardiol 62 2013 263 271
15. V. Sekhri, S. Sanal, L.J. DeLorenzo, W.S. Aronow, and G.P. Maguire Cardiac sarcoidosis: a comprehensive review Arch Med Sci 7 4 2011 546 554
16. S.A. Hunt, W.T. Abraham, and M.H. Chin et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 14 2009 e391 e479
17. R.P. Baughman, A.S. Teirstein, and M.A. Judson et al. Clinical characteristics of patients in a case control study of sarcoidosis Am J Respir Crit Care Med 164 2001 1885 1889
18. G. Quarta, D.R. Holdright, and G.T. Plant et al. Cardiovascular magnetic resonance in cardiac sarcoidosis with MR conditional pacemaker in situ J Cardiovasc Magn Reson 13 2011 26
19. L. Fang, A. Beale, and A.H. Ellims et al. Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy J Am Heart Assoc 2 5 2013 e000270